Stoke Therapeutics, Inc. ( STOK) - Key Metrics
STOK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.02 | -$0.99 | -$0.52 | -$0.53 |
| 2025Q3 | $0.18 | -$0.65 | -$0.52 | -$0.52 |
| 2025Q2 | $0.24 | -$0.40 | -$0.44 | -$0.44 |
| 2025Q1 | $2.74 | $1.95 | $2.28 | $2.28 |
STOK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.00 |
| 2025Q3 | ? | -8.98 |
| 2025Q2 | ? | -7.05 |
| 2025Q1 | ? | 0.85 |
STOK
Price: $30
52 week price:
Earnings Per Share: -2.86 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 66686
Market Capitalization: 1.8 billion